Ex-10.14 Summary of Director and Executive Officer Compensation
Contract Categories:
Human Resources
- Compensation Agreements
EX-10.14 2 g12487exv10w14.htm EX-10.14 SUMMARY OF DIRECTOR AND EXECUTIVE OFFICER COMPENSATION Ex-10.14
EXHIBIT 10.14
HealthStream, Inc. (the Company)
Summary of Director and Executive Officer Compensation
I. Director Compensation. Directors who are employees of the Company do not receive additional compensation for serving as directors of the Company. The following table sets forth current rates of cash compensation for the Companys non-employee directors.
Retainers and Fees | 2007 | |||
Board meeting fee | $ | 1,000 | ||
Committee chair meeting fee | $ | 1,000 | ||
Committee member meeting fee | $ | 500 |
In addition to the cash compensation set forth above, each non-employee director receives a nondiscretionary annual grant of a non-qualified option for the purchase of 6,000 shares of the Companys common stock. The option, which vests immediately upon grant, has an exercise price equal to the fair market value of the stock on the grant date.
II. Executive Officer Compensation. The following table sets forth the current base salaries and the fiscal 2007 performance bonuses provided to the individuals who the Company expects to be its Named Executive Officers for 2007.
Executive Officer | Current Salary | Fiscal 2007 Bonus Amount | ||||||
Robert A. Frist, Jr. | $ | 195,000 | $ | -0- | ||||
Arthur E. Newman | $ | 205,000 | $ | -0- | ||||
J. Edward Pearson | $ | 210,000 | $ | -0- | ||||
Kevin P. OHara | $ | 185,000 | $ | -0- |
The Named Executive Officers also participate in the Companys 2008 Cash Bonus Plan and will continue to receive long-term incentive awards pursuant to the Companys shareholder approved equity incentive plans.
III. Additional Information. The foregoing information is summary in nature. Additional information regarding Director and Named Executive Officer compensation will be contained in our proxy statement for the 2008 Annual Meeting of Shareholders that we will file with the Securities and Exchange Commission within 120 days of the end of the fiscal year to which this report relates.